Article
CXCR6 deficiency impairs cancer vaccine efficacy and CD8+ resident memory T-cell recruitment in head and neck and lung tumors.
Journal for immunotherapy of cancer - 1 Mar 2021
Karaki Soumaya, Blanc Charlotte, Tran Thi, Galy-Fauroux Isabelle, Mougel Alice, Dransart Estelle, Anson Marie, Tanchot Corinne, Paolini Lea, Gruel Nadege, Gibault Laure, Lepimpec-Barhes Francoise, Fabre Elizabeth, Benhamouda Nadine, Badoual Cecile, Damotte Diane, Donnadieu Emmanuel, Kobold Sebastian, Mami-Chouaib Fathia, Golub Rachel, Johannes Ludger, Tartour Eric
Abstract excerpt
BACKGROUND: Resident memory T lymphocytes (TRM) are located in tissues and play an important role in immunosurveillance against tumors. The presence of TRM prior to treatment or their induction is associated to the response to anti-Programmed cell death protein 1 (PD-1)/Programmed death-ligand 1 (PD-L1) immunotherapy and the efficacy of cancer vaccines. Previous work by our group and others has shown that the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
